T. Rowe Price Investment Management, Inc. Elanco Animal Health Inc Transaction History
T. Rowe Price Investment Management, Inc.
- $158 Billion
- Q2 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Elanco Animal Health Inc stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 9,770,460 shares of ELAN stock, worth $143 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
9,770,460
Previous 9,348,613
4.51%
Holding current value
$143 Million
Previous $152 Million
7.36%
% of portfolio
0.09%
Previous 0.09%
Shares
4 transactions
Others Institutions Holding ELAN
# of Institutions
446Shares Held
478MCall Options Held
3.1MPut Options Held
1.26M-
Dodge & Cox San Francisco, CA83.6MShares$1.23 Billion0.76% of portfolio
-
Primecap Management CO Pasadena, CA52.8MShares$775 Million0.56% of portfolio
-
Vanguard Group Inc Valley Forge, PA49.4MShares$725 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD28.1MShares$412 Million0.05% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$342 Million0.01% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $6.96B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...